Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Elafibranor> ?p ?o }
Showing triples 1 to 63 of
63
with 100 triples per page.
- Elafibranor abstract "Elafibranor (GFT505) a experimental medication that is being studied and developed by Genfit for the treatment of cardiometabolic diseases including diabetes, insulin resistance, dyslipidemia, and non-alcoholic fatty liver disease (NAFLD).Elafibranor is a dual PPARα/δ agonist.Elifibranor is mainly focused on the treatment of NASH disease.".
- Elafibranor atcPrefix "none".
- Elafibranor casNumber "923978-27-2".
- Elafibranor iupacName "2-[2,6 dimethyl-4-[3-[4-(methylthio)phenyl]-3-oxo-1(E)-propenyl]phenoxyl]-2-methylpropanoic acid".
- Elafibranor pubchem "9864881".
- Elafibranor thumbnail Elafibranor.svg?width=300.
- Elafibranor wikiPageExternalLink www.genfit.com.
- Elafibranor wikiPageExternalLink www.nashbiotechs.com.
- Elafibranor wikiPageID "38972749".
- Elafibranor wikiPageLength "6864".
- Elafibranor wikiPageOutDegree "9".
- Elafibranor wikiPageRevisionID "702930373".
- Elafibranor wikiPageWikiLink Category:PPAR_agonists.
- Elafibranor wikiPageWikiLink Diabetes_mellitus.
- Elafibranor wikiPageWikiLink Dyslipidemia.
- Elafibranor wikiPageWikiLink Genfit.
- Elafibranor wikiPageWikiLink Insulin_resistance.
- Elafibranor wikiPageWikiLink MBX-8025.
- Elafibranor wikiPageWikiLink Non-alcoholic_fatty_liver_disease.
- Elafibranor wikiPageWikiLink PPAR_agonist.
- Elafibranor wikiPageWikiLink Telmisartan.
- Elafibranor wikiPageWikiLinkText "Elafibranor".
- Elafibranor atcPrefix "none".
- Elafibranor c "22".
- Elafibranor casNumber "923978".
- Elafibranor chemspiderid "8040573".
- Elafibranor h "24".
- Elafibranor iupacName "2".
- Elafibranor legalStatus "Investigational".
- Elafibranor molecularWeight "384.489".
- Elafibranor o "4".
- Elafibranor pregnancyCategory "N/A".
- Elafibranor pubchem "9864881".
- Elafibranor s "1".
- Elafibranor smiles "O=CCC".
- Elafibranor stdinchi "1".
- Elafibranor stdinchikey "AFLFKFHDSCQHOL-IZZDOVSWSA-N".
- Elafibranor synonyms "GFT505, SureCN815512".
- Elafibranor wikiPageUsesTemplate Template:As_of.
- Elafibranor wikiPageUsesTemplate Template:Drugbox.
- Elafibranor wikiPageUsesTemplate Template:Gastrointestinal-drug-stub.
- Elafibranor wikiPageUsesTemplate Template:Nuclear_receptor_ligands.
- Elafibranor wikiPageUsesTemplate Template:Reflist.
- Elafibranor subject Category:PPAR_agonists.
- Elafibranor type ChemicalSubstance.
- Elafibranor type Drug.
- Elafibranor type Agonist.
- Elafibranor type Chemical.
- Elafibranor type Drug.
- Elafibranor type ChemicalObject.
- Elafibranor type Thing.
- Elafibranor type Q8386.
- Elafibranor comment "Elafibranor (GFT505) a experimental medication that is being studied and developed by Genfit for the treatment of cardiometabolic diseases including diabetes, insulin resistance, dyslipidemia, and non-alcoholic fatty liver disease (NAFLD).Elafibranor is a dual PPARα/δ agonist.Elifibranor is mainly focused on the treatment of NASH disease.".
- Elafibranor label "Elafibranor".
- Elafibranor sameAs Q15409440.
- Elafibranor sameAs Elafibranor.
- Elafibranor sameAs m.0s9c6dm.
- Elafibranor sameAs GFT505.
- Elafibranor sameAs GFT505.
- Elafibranor sameAs Q15409440.
- Elafibranor wasDerivedFrom Elafibranor?oldid=702930373.
- Elafibranor depiction Elafibranor.svg.
- Elafibranor isPrimaryTopicOf Elafibranor.